Abstract
Purpose of Review
To evaluate remote monitoring using implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) devices as an adjunctive tool to the traditional care of patients with heart failure (HF).
Recent Findings
We included 11 trials encompassing 5965 patients. Absolute risk difference (ARD) with 95% credible interval (CrI) was estimated. Pooled (posterior) risk difference was computed using Bayesian hierarchical methods. The ARD for mortality was centered at − 0.01 (95% CrI: − 0.03; 0.01, Tau: 0.02), with an 82% probability of ARD of ICD/CRT-D remote monitoring with respect to control being less than 0. The ARD for cardiovascular mortality was centered at − 0.03 (95% CrI: − 0.11; 0.05, Tau: 0.10), with an 84% probability of ARD of ICD/CRT-D remote monitoring with respect to control being less than 0.
Summary
ICD/CRT-D remote monitoring in patients with HF is associated with a higher probability of reduced all-cause and cardiovascular mortality compared with standard care alone.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–596. https://doi.org/10.1161/CIR.0000000000000757.
Chamberlain RS, Sond J, Mahendraraj K, Lau CS, Siracuse BL. Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale. Int J Gen Med. 2018;11:127–41. https://doi.org/10.2147/IJGM.S150676.
McDermott MM, Feinglass J, Sy J, Gheorghiade M. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med. 1995;99(6):629–35. https://doi.org/10.1016/s0002-9343(99)80250-2.
Ong MK, Romano PS, Edgington S, et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the Better Effectiveness After Transition – Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med. 2016;176(3):310–8. https://doi.org/10.1001/jamainternmed.2015.7712.
Brahmbhatt DH, Cowie MR. Remote management of heart failure: an overview of telemonitoring technologies. Card Fail Rev. 2019;5(2):86–92. https://doi.org/10.15420/cfr.2019.5.3.
Halawa A, Enezate T, Flaker G. Device monitoring in heart failure management: outcomes based on a systematic review and meta-analysis. Cardiovasc Diagn Ther. 2019;9(4):386–93. https://doi.org/10.21037/cdt.2019.01.02.
Cheuk-Man Y, Li W, Elaine C, et al. Intrathoracic impedance monitoring in patients with heart failure. Circulation. 2005;112(6):841–8. https://doi.org/10.1161/CIRCULATIONAHA.104.492207.
Cowie MR. Monitoring heart failure using an implantable device measuring intrathoracic impedance - technical and clinical overview. Eur Cardiol. 2005;1(1):1–4.
Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet (London, England). 2014;384(9943):583–590. https://doi.org/10.1016/S0140-6736(14)61176-4. The authors showed that remote monitoring decreased the primary outcome and showed survival benefit.
van Veldhuisen DJ, Braunschweig F, Conraads V, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124(16):1719–26. https://doi.org/10.1161/CIRCULATIONAHA.111.043042.
Hansen C, Loges C, Seidl K, et al. INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact). BMC Cardiovasc Disord. 2018;18(1):131. https://doi.org/10.1186/s12872-018-0864-7.
Sardu C, Santamaria M, Rizzo MR, et al. Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study. Int J Clin Pract. 2016;70(7):569–76. https://doi.org/10.1111/ijcp.12823.
Domenichini G, Rahneva T, Diab IG, et al. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study). Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol. 2016;18(3):428–35. https://doi.org/10.1093/europace/euv293.
Lüthje L, Vollmann D, Seegers J, Sohns C, Hasenfuß G, Zabel M. A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices. Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol. 2015;17(8):1276–81. https://doi.org/10.1093/europace/euv039.
Boriani G, Da Costa A, Quesada A, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017;19(3):416–25. https://doi.org/10.1002/ejhf.626.
Böhm M, Drexler H, Oswald H, et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J. 2016;37(41):3154–63. https://doi.org/10.1093/eurheartj/ehw099.
Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation. 2012;125(24):2985–92. https://doi.org/10.1161/CIRCULATIONAHA.111.088971.
Tajstra M, Sokal A, Gadula-Gacek E, et al. Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator.Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol. 2020;22(5):769-776.https://doi.org/10.1093/europace/euaa072. The authors showed that remote monitoring was associated with reduced cardiovascular hospitalizations but did not affect mortality.
Morgan JM, Kitt S, Gill J, et al. Remote management of heart failure using implantable electronic devices. Eur Heart J. 2017;38(30):2352–60. https://doi.org/10.1093/eurheartj/ehx227.
van Tulder M, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976). 2003;28(12):1290–1299. https://doi.org/10.1097/01.BRS.0000065484.95996.AF
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, W64. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928.
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.
Bittl JA, He Y. Bayesian analysis: a practical approach to interpret clinical trials and create clinical practice guidelines. Circ Cardiovasc Qual Outcomes. 2017;10(8). https://doi.org/10.1161/CIRCOUTCOMES.117.003563
Röver C. Bayesian random-effects meta-analysis using the bayesmeta R Package. J Stat Softw. 2020;93(6):1–51. https://doi.org/10.18637/jss.v093.i06.
De Simone A, Leoni L, Luzi M, et al. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. Eur Eur pacing, arrhythmias, Card Electrophysiol J Work groups Card pacing, arrhythmias, Card Cell Electrophysiol Eur Soc Cardiol. 2015;17(8):1267–75. https://doi.org/10.1093/europace/euu318.
Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane database Syst Rev. 2010;(8):CD007228. https://doi.org/10.1002/14651858.CD007228.pub2. The authors included 25 trials and found a reduction in death rate by 44% and HF-related hospitalizations by 21.6% among patients with telemononitoring.
Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363(24):2301–9. https://doi.org/10.1056/NEJMoa1010029.
Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J. 2011;32(18):2266–73. https://doi.org/10.1093/eurheartj/ehr050.
Parthiban N, Esterman A, Mahajan R, et al. Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol. 2015;65(24):2591–600. https://doi.org/10.1016/j.jacc.2015.04.029.
Klersy C, Boriani G, De Silvestri A, et al. Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized controlled trials in patients with heart failure. Eur J Heart Fail. 2016;18(2):195–204. https://doi.org/10.1002/ejhf.470.
Al-Khatib SM, Piccini JP, Knight D, Stewart M, Clapp-Channing N, Sanders GD. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol. 2010;21(5):545–50. https://doi.org/10.1111/j.1540-8167.2009.01659.x.
Ošmera O, Bulava A. The benefits of remote monitoring in long-term care for patients with implantable cardioverter-defibrillators. Neuro Endocrinol Lett. 2014;35(Suppl 1):40–8.
Perl S, Stiegler P, Rotman B, et al. Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial). Int J Cardiol. 2013;169(6):402–7. https://doi.org/10.1016/j.ijcard.2013.10.019.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The Editors would like to thank Dr. Christianne Angermann for handling the review of this manuscript.
This article is part of the Topical Collection on Clinical Heart Failure
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Al-Abdouh, A., Mhanna, M., Sayaideh, M.A. et al. Efficacy of ICD/CRT-D Remote Monitoring in Patients With HFrEF: a Bayesian Meta-analysis of Randomized Controlled Trials. Curr Heart Fail Rep 19, 435–444 (2022). https://doi.org/10.1007/s11897-022-00579-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11897-022-00579-6